Elias Kouchakji is SVP, Clinical Dev, Drug Safety of FIBROGEN INC. Currently has a direct ownership of 147,346 shares of FGEN, which is worth approximately $57,464. The most recent transaction as insider was on Mar 08, 2021, when has been sold 5,221 shares (Common Stock) at a price of $33.37 per share, resulting in proceeds of $174,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 147K
0% 3M change
0% 12M change
Total Value Held $57,464

Elias Kouchakji Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2021
SELL
Payment of exercise price or tax liability
$174,225 $33.37 p/Share
5,221 Reduced 3.42%
147,346 Common Stock
Feb 24 2021
BUY
Grant, award, or other acquisition
-
20,800 Added 12.0%
152,567 Common Stock
Dec 07 2020
SELL
Payment of exercise price or tax liability
$114,549 $41.99 p/Share
2,728 Reduced 2.03%
131,767 Common Stock
Nov 17 2020
BUY
Exercise of conversion of derivative security
$103,185 $14.57 p/Share
7,082 Added 5.0%
134,495 Common Stock
EK

Elias Kouchakji

SVP, Clinical Dev, Drug Safety
San Francisco, CA

Track Institutional and Insider Activities on FGEN

Follow FIBROGEN INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FGEN shares.

Notify only if

Insider Trading

Get notified when an Fibrogen Inc insider buys or sells FGEN shares.

Notify only if

News

Receive news related to FIBROGEN INC

Track Activities on FGEN